ARCHIVES

In Brief: FDA’s Tabor To Head Biological Carcinogenesis in DCE; Steve Larson to Leave NIH for Memorial

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

The Cancer Letter To End Print Edition In January

November 20, 2009

Preventive Oncology Announcement Withdrawn For Modification

April 3, 1981

Clinton to Propose Increase for NIH & NCI Significantly Higher Than In Previous Years

January 9, 1998

Q & A With Shannon Brownlee: Task Force Independence at Stake In Debate over PSA Screening

October 6, 2011

Search for New NCI director focuses On California; Possibilities Include Korn, Beahrs, Gale, Others

September 23, 1988

Patients on Hypertension Meds Lived Longer, Analysis Shows

January 31, 2014